VYGR
Voyager Therapeutics Inc
2.40$
-4.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -456.2% | -26.4% | 301.1% | -106.8% | -113.6% | -231.4% | -585.4% | -639.6% | -232.3% | -197.3% | -1,288.8% | -816.5% | -349.9% | |
| 20.5% | 1.5% | 6.1% | 4.7% | 4.6% | 16.1% | 15.7% | 20.5% | 7.0% | 6.8% | 21.9% | 28.7% | 10.0% | |
| 62.4% | 3.4% | 18.3% | 13.7% | 13.9% | 59.5% | 56.7% | 79.5% | 25.9% | 23.0% | 96.0% | 76.9% | 34.5% | |
| 61.0% | -91.9% | 338.9% | -89.1% | -87.8% | 265.9% | -182.5% | -59.9% | -51.6% | -45.2% | -378.2% | -249.4% | -91.5% | |
| 16.9% | 0.8% | 11.0% | 3.3% | 1.0% | 2.5% | 10.2% | 21.3% | 1.5% | 4.1% | 0.5% | 0.4% | 2.5% | |
| -3,430.9% | 29.8% | -492.2% | -121.5% | 261.3% | -433.3% | 636.5% | 37.2% | 261.0% | 309.2% | 312.4% | 486.3% | 307.0% | |
| – | – | 98.9% | – | – | – | – | 8.3% | – | – | – | – | – | |
| 7.2% | 0.5% | 578.3% | 1.9% | 0.1% | 9.1% | 1.3% | 9.9% | 0.6% | 0.9% | 128.5% | 91.8% | 18.7% | |
| -3,880.0% | 3.9% | 387.2% | -226.4% | 147.8% | -655.6% | 52.3% | -592.6% | 8.9% | 112.8% | -847.9% | -238.4% | -32.1% | |
| -473.2% | -27.2% | 290.2% | -110.0% | -114.6% | -233.9% | -595.6% | -660.9% | -233.9% | -201.4% | -1,289.4% | -816.5% | -352.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.